Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Amortizatization of Intangibles: 2010-2014

Historic Amortizatization of Intangibles for Gyre Therapeutics (GYRE) over the last 5 years, with Dec 2014 value amounting to $775,000.

  • Gyre Therapeutics' Amortizatization of Intangibles fell 72.12% to $63,000 in Q2 2015 from the same period last year, while for Jun 2015 it was $484,000, marking a year-over-year decrease of 41.62%. This contributed to the annual value of $775,000 for FY2014, which is 14.65% down from last year.
  • Gyre Therapeutics' Amortizatization of Intangibles amounted to $775,000 in FY2014, which was down 14.65% from $908,000 recorded in FY2013.
  • In the past 5 years, Gyre Therapeutics' Amortizatization of Intangibles ranged from a high of $937,000 in FY2012 and a low of $416,000 during FY2010.
  • Over the past 3 years, Gyre Therapeutics' median Amortizatization of Intangibles value was $908,000 (recorded in 2013), while the average stood at $873,333.
  • As far as peak fluctuations go, Gyre Therapeutics' Amortizatization of Intangibles skyrocketed by 118.99% in 2011, and later decreased by 14.65% in 2014.
  • Gyre Therapeutics' Amortizatization of Intangibles (Yearly) stood at $416,000 in 2010, then skyrocketed by 118.99% to $911,000 in 2011, then climbed by 2.85% to $937,000 in 2012, then decreased by 3.09% to $908,000 in 2013, then dropped by 14.65% to $775,000 in 2014.